The acceptability of seasonal antimalarial medication in Korogho, Côte d'Ivoire

Phase 3

• Conditions: Malaria; Infections and Infestations; Unspecified malaria

• Registration Number: ISRCTN17164969
• Lead Sponsor: Institut de Recherche en Sciences de la Santé

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-07-02
• Last Update Posted: 4 January 2022
• Study Completion: 2022-03-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 1701

Inclusion Criteria

1. Both sexes
2. Resident of the study area
3. Willingness to remain in the study area during the study
4. Age between 3 and 59 months
5. Provision of signed informed consent
6. Absence of severe malnutrition or severe condition

Exclusion Criteria

1. Absence of provision of informed consent
2. Age less than 3 months and more than 59 months
3. Presence of severe malnutrition or other severe condition
4. Residing outside the study area

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of children aged 3 - 59 months (at the time of first SMC cycle) who received five monthly treatments of SMC measured using patient records one month after the last round of treatment (in December)